CD47 and osteosarcoma: KHOS/NP osteosarcoma cells were labeled with carboxyfluorescein succinimidyl ester and pretreated with B6H12 antibody to assess the potential enhancement of macrophage-mediated phagocytosis in osteosarcoma cells mediated by the CD47 antibody.